Related Experiment Videos
Refined structure of the hirudin-thrombin complex
T J Rydel1, A Tulinsky, W Bode
1Department of Chemistry, Michigan State University, East Lansing 48824.
Journal of Molecular Biology
|September 20, 1991
Summary
The recombinant hirudin (variant 2, Lys47) complexed with human alpha-thrombin reveals unique binding interactions. Hirudin
Area of Science:
- Biochemistry and structural biology
- Protein-protein interactions
- Enzyme inhibition
Background:
- Thrombin is a key enzyme in blood coagulation.
- Hirudin is a potent natural inhibitor of thrombin.
- Understanding their complex structure is crucial for drug development.
Purpose of the Study:
- To determine the high-resolution structure of the recombinant hirudin-thrombin complex.
- To elucidate the molecular interactions responsible for thrombin inhibition by hirudin.
Main Methods:
- X-ray crystallography
- Restrained least-squares refinement
- Structural analysis
Main Results:
- The hirudin N-terminal domain binds to the thrombin active site, interacting with the catalytic triad.
- Hirudin forms a parallel beta-strand with thrombin, differing from other serine proteinase inhibitors.
- The C-terminal segment of hirudin interacts with the fibrinogen binding exosite via electrostatic and hydrophobic interactions.
- High affinity and specificity result from numerous, collectively strong interactions.
Conclusions:
- The precise complementarity between hirudin and thrombin underlies their strong binding.
- Structural differences in the autolysis loop are likely due to crystal packing.
- The RGD sequence in thrombin may not mediate surface interactions in this complex.